Legal Counsel for a Hong Kong-Based Venture Capital Firm on Investment Diligence
Edward Tung, legal counsel for Hong Kong-based venture capital firm ORI Capital, discusses the growing importance of ESG, the rise of special purpose acquisition companies and the advantage of having scientific expertise when representing health care and biotechnology companies.
August 20, 2021 at 02:17 PM
6 minute read
The original version of this story was published on Law.com International
Edward Tung is legal counsel, head of compliance and chairman of the risk management committee for ORI Capital, a Hong Kong-based venture capital firm launched in 2015 that focuses on investing in innovative health care companies globally. ORI Healthcare Fund has a fund size of $200 million, while ORI Healthcare Fund II has a target fund size of $400 million. Before joining the firm in 2019, Tung was an associate at the Hong Kong-based international law firm Deacons. We asked him about the growing importance of ESG, the rise of special purpose acquisition companies (SPACs) in the United States and his decision to switch from working in science to working in the law. This Q&A has been lightly edited for clarity and brevity.
You are one of very few lawyers who has a Ph.D. in microbiology. What made you decide to pursue a career in law?
I had always wanted to be a scientist. It is why I studied for a Ph.D. at the Faculty of Medicine of the University of Hong Kong. However, I gradually came to realize that a career in science was not the right fit for me. As many of my friends and collaborators at university went on to set up their health care or biotechnology companies, they told me that they had difficulty finding the right lawyers in Hong Kong to represent them—lawyers who really understood their business. That's why I started looking into becoming a lawyer. I felt that being a lawyer would allow me to operate in both the commercial and the scientific worlds. I aspire to be the bridge between inventors and investors.
Why is it so important for health care firms to have lawyers that really understand their business?
It is really important because a lot of our work involves assessing the scientific viability of new treatments, medicines or devices. I work with my colleagues, some who also have doctorate degrees in related fields, in the investment due diligence process to identify investment targets. Although our scientific team is primarily responsible for scientific due diligence, the patent due diligence, which is a crucial part of our legal due diligence, often goes to the fundamentals of the technology. For me, this job entails reading the original scientific papers of new discoveries in relevant areas.
This role requires assessing "binary" scientific risks, meaning that a proposed health intervention could have zero value if it is, in fact, ineffective or potentially a poison rather than a medicine
There are many technical details that your typical transaction lawyer may miss unless they have prior knowledge in this field. For example, milestone payments in health care investments are often relevant to a company's research or clinical trial progress, and it is much easier for someone with the technical knowledge to prepare the documents.
My academic background helps me carry out my responsibilities as the chair of the firm's risk management committee. This role requires assessing "binary" scientific risks, meaning that a proposed health intervention could have zero value if it is, in fact, ineffective or potentially a poison rather than a medicine.
ESG is becoming a popular issue both in Hong Kong and mainland China. How has ESG affected your work?
It's a bit embarrassing to say, but we only started reporting our fund's ESG data to investors in 2020. Even though there are no hard rules in Hong Kong requiring us to do that, we still think it's a good thing to do and we believe it will be good for our investors to have a better understanding of how good our fund is performing from a social impact perspective.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllFinancial Services Has a Trust Problem. Can GCs Help Right the Ship?
More Aspiring GCs Finding Fulfillment in Wild and Woolly Realm of Private Equity
Food-Waste Company Divert—Backed by $1.1B in Funding—Hires First General Counsel
Trending Stories
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250